208 related articles for article (PubMed ID: 35392903)
1. SNAP25 is a potential prognostic biomarker for prostate cancer.
Di L; Gu M; Wu Y; Liu G; Zhang L; Li Y; Zhang W
Cancer Cell Int; 2022 Apr; 22(1):144. PubMed ID: 35392903
[TBL] [Abstract][Full Text] [Related]
2. A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer.
Su Q; Zhu Y; He B; Dai B; Mu W; Tian J
Eur J Med Res; 2023 Nov; 28(1):545. PubMed ID: 38017548
[TBL] [Abstract][Full Text] [Related]
3. Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
Zou J; Duan D; Yu C; Pan J; Xia J; Yang Z; Cai S
PeerJ; 2020; 8():e10142. PubMed ID: 33150073
[TBL] [Abstract][Full Text] [Related]
4. Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer.
Zhang Q; Zhang P; Zhao Z; Wang J; Zhang H
PeerJ; 2023; 11():e15013. PubMed ID: 37070095
[TBL] [Abstract][Full Text] [Related]
5. LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.
Shi J; Jiang D; Yang S; Zhang X; Wang J; Liu Y; Sun Y; Lu Y; Yang K
Front Oncol; 2020; 10():846. PubMed ID: 32656075
[TBL] [Abstract][Full Text] [Related]
6. Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Liu S; Wang W; Zhao Y; Liang K; Huang Y
Front Oncol; 2020; 10():809. PubMed ID: 32547947
[No Abstract] [Full Text] [Related]
7. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
8. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
9. Identification of Pathologic and Prognostic Genes in Prostate Cancer Based on Database Mining.
Liu K; Chen Y; Feng P; Wang Y; Sun M; Song T; Tan J; Li C; Liu S; Kong Q; Zhang J
Front Genet; 2022; 13():854531. PubMed ID: 35360870
[No Abstract] [Full Text] [Related]
10. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
11. MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer.
Jiao M; Zhang F; Teng W; Zhou C
Int J Gen Med; 2022; 15():3003-3030. PubMed ID: 35313552
[TBL] [Abstract][Full Text] [Related]
12. EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients.
Liao Y; Wu M; Jia Y; Mou R; Li X
Front Cell Dev Biol; 2022; 10():843604. PubMed ID: 35517503
[No Abstract] [Full Text] [Related]
13. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
Lyu F; Li Y; Yan Z; He Q; Cheng L; Zhang P; Liu B; Liu C; Song Y; Xing Y
J Transl Med; 2022 May; 20(1):202. PubMed ID: 35538543
[TBL] [Abstract][Full Text] [Related]
14. HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer.
Li Z; Wei R; Yao S; Meng F; Kong L
Heliyon; 2024 Jan; 10(2):e24664. PubMed ID: 38298716
[TBL] [Abstract][Full Text] [Related]
15. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
16. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
[TBL] [Abstract][Full Text] [Related]
17. UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.
Wang Z; Wang Y; Peng M; Yi L
Front Oncol; 2019; 9():1517. PubMed ID: 32010618
[No Abstract] [Full Text] [Related]
18. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
19. GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.
Peng Q; Xie T; Wang Y; Ho VW; Teoh JY; Chiu PK; Ng CF
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203661
[TBL] [Abstract][Full Text] [Related]
20. Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer.
Guo L; Lin M; Cheng Z; Chen Y; Huang Y; Xu K
PeerJ; 2019; 7():e7899. PubMed ID: 31637138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
